Global Neurostimulation Devices Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	168 Pages	TechNavio	August, 2023	INF18192860

Best Price Guarantee
Price	from $2,500
Length	168 Pages
Publisher	TechNavio
Published Date	August, 2023
SKU	INF18192860

Global Neurostimulation Devices Market 2023-2027

The neurostimulation devices market is forecasted to grow by USD 6,257.05 mn during 2022-2027, accelerating at a CAGR of 12.19% during the forecast period. The report on the neurostimulation devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of neurological disorders, increasing number of initiatives to increase awareness of and access to neurological healthcare, and rapid increase in geriatric population.

Technavio's neurostimulation devices market is segmented as below:

By Application

Pain management
Urinary and fecal incontinence
Parkinsons disease
Epilepsy
Others

By Product

Implantable neurostimulation devices
External neurostimulation devices

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expanding indications of neurostimulation devices as one of the prime reasons driving the neurostimulation devices market growth during the next few years. Also, increasing number of initiatives supporting research related to neurostimulation technology and technological advances in neurostimulation devices will lead to sizable demand in the market.

The report on the neurostimulation devices market covers the following areas:

Neurostimulation devices market sizing
Neurostimulation devices market forecast
Neurostimulation devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurostimulation devices market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Axonics Inc., Bayer AG, Bioinduction Ltd, Boston Scientific Corp., electroCore Inc., EndoStim Inc, Integer Holdings Corp., LABORIE MEDICAL TECHNOLOGIES CORP., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Parasym, Perflow Medical Ltd., Soterix Medical Inc., and Synapse Biomedical Inc. Also, the neurostimulation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by Product; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global neurostimulation devices market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global neurostimulation devices market 2017 - 2021 ($ million); 4.2 Application Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million); 4.3 Product Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2022-2027 (%); Exhibit 31: Data Table on Application - Market share 2022-2027 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 Pain management - Market size and forecast 2022-2027; Exhibit 34: Chart on Pain management - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Pain management - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Pain management - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Pain management - Year-over-year growth 2022-2027 (%); 6.4 Urinary and fecal incontinence - Market size and forecast 2022-2027; Exhibit 38: Chart on Urinary and fecal incontinence - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Urinary and fecal incontinence - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Urinary and fecal incontinence - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Urinary and fecal incontinence - Year-over-year growth 2022-2027 (%); 6.5 Parkinsons disease - Market size and forecast 2022-2027; Exhibit 42: Chart on Parkinsons disease - Market size and forecast 2022-2027 ($ million); Exhibit 43: Data Table on Parkinsons disease - Market size and forecast 2022-2027 ($ million); Exhibit 44: Chart on Parkinsons disease - Year-over-year growth 2022-2027 (%); Exhibit 45: Data Table on Parkinsons disease - Year-over-year growth 2022-2027 (%); 6.6 Epilepsy - Market size and forecast 2022-2027; Exhibit 46: Chart on Epilepsy - Market size and forecast 2022-2027 ($ million); Exhibit 47: Data Table on Epilepsy - Market size and forecast 2022-2027 ($ million); Exhibit 48: Chart on Epilepsy - Year-over-year growth 2022-2027 (%); Exhibit 49: Data Table on Epilepsy - Year-over-year growth 2022-2027 (%); 6.7 Others - Market size and forecast 2022-2027; Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.8 Market opportunity by Application; Exhibit 54: Market opportunity by Application ($ million); Exhibit 55: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Exhibit 56: Chart on Product - Market share 2022-2027 (%); Exhibit 57: Data Table on Product - Market share 2022-2027 (%); 7.2 Comparison by Product; Exhibit 58: Chart on Comparison by Product; Exhibit 59: Data Table on Comparison by Product; 7.3 Implantable neurostimulation devices - Market size and forecast 2022-2027; Exhibit 60: Chart on Implantable neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibit 61: Data Table on Implantable neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibit 62: Chart on Implantable neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibit 63: Data Table on Implantable neurostimulation devices - Year-over-year growth 2022-2027 (%); 7.4 External neurostimulation devices - Market size and forecast 2022-2027; Exhibit 64: Chart on External neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibit 65: Data Table on External neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibit 66: Chart on External neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibit 67: Data Table on External neurostimulation devices - Year-over-year growth 2022-2027 (%); 7.5 Market opportunity by Product; Exhibit 68: Market opportunity by Product ($ million); Exhibit 69: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 Germany - Market size and forecast 2022-2027; Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.9 UK - Market size and forecast 2022-2027; Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.10 Japan - Market size and forecast 2022-2027; Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%); 9.11 China - Market size and forecast 2022-2027; Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 119: Abbott Laboratories - Overview; Exhibit 120: Abbott Laboratories - Business segments; Exhibit 121: Abbott Laboratories - Key news; Exhibit 122: Abbott Laboratories - Key offerings; Exhibit 123: Abbott Laboratories - Segment focus; 12.4 ALEVA NEUROTHERAPEUTICS SA; Exhibit 124: ALEVA NEUROTHERAPEUTICS SA - Overview; Exhibit 125: ALEVA NEUROTHERAPEUTICS SA - Product / Service; Exhibit 126: ALEVA NEUROTHERAPEUTICS SA - Key offerings; 12.5 Bayer AG; Exhibit 127: Bayer AG - Overview; Exhibit 128: Bayer AG - Business segments; Exhibit 129: Bayer AG - Key news; Exhibit 130: Bayer AG - Key offerings; Exhibit 131: Bayer AG - Segment focus; 12.6 Boston Scientific Corp.; Exhibit 132: Boston Scientific Corp. - Overview; Exhibit 133: Boston Scientific Corp. - Business segments; Exhibit 134: Boston Scientific Corp. - Key news; Exhibit 135: Boston Scientific Corp. - Key offerings; Exhibit 136: Boston Scientific Corp. - Segment focus; 12.7 electroCore Inc.; Exhibit 137: electroCore Inc. - Overview; Exhibit 138: electroCore Inc. - Product / Service; Exhibit 139: electroCore Inc. - Key offerings; 12.8 EndoStim Inc; Exhibit 140: EndoStim Inc - Overview; Exhibit 141: EndoStim Inc - Product / Service; Exhibit 142: EndoStim Inc - Key offerings; 12.9 LABORIE MEDICAL TECHNOLOGIES CORP.; Exhibit 143: LABORIE MEDICAL TECHNOLOGIES CORP. - Overview; Exhibit 144: LABORIE MEDICAL TECHNOLOGIES CORP. - Product / Service; Exhibit 145: LABORIE MEDICAL TECHNOLOGIES CORP. - Key offerings; 12.10 LivaNova Plc; Exhibit 146: LivaNova Plc - Overview; Exhibit 147: LivaNova Plc - Business segments; Exhibit 148: LivaNova Plc - Key offerings; Exhibit 149: LivaNova Plc - Segment focus; 12.11 Medtronic Plc; Exhibit 150: Medtronic Plc - Overview; Exhibit 151: Medtronic Plc - Business segments; Exhibit 152: Medtronic Plc - Key news; Exhibit 153: Medtronic Plc - Key offerings; Exhibit 154: Medtronic Plc - Segment focus; 12.12 NeuroMetrix Inc.; Exhibit 155: NeuroMetrix Inc. - Overview; Exhibit 156: NeuroMetrix Inc. - Product / Service; Exhibit 157: NeuroMetrix Inc. - Key offerings; 12.13 NEURONETICS Inc.; Exhibit 158: NEURONETICS Inc. - Overview; Exhibit 159: NEURONETICS Inc. - Product / Service; Exhibit 160: NEURONETICS Inc. - Key offerings; 12.14 NeuroPace Inc.; Exhibit 161: NeuroPace Inc. - Overview; Exhibit 162: NeuroPace Inc. - Product / Service; Exhibit 163: NeuroPace Inc. - Key offerings; 12.15 Nevro Corp.; Exhibit 164: Nevro Corp. - Overview; Exhibit 165: Nevro Corp. - Product / Service; Exhibit 166: Nevro Corp. - Key offerings; 12.16 Soterix Medical Inc.; Exhibit 167: Soterix Medical Inc. - Overview; Exhibit 168: Soterix Medical Inc. - Product / Service; Exhibit 169: Soterix Medical Inc. - Key offerings; 12.17 Synapse Biomedical Inc.; Exhibit 170: Synapse Biomedical Inc. - Overview; Exhibit 171: Synapse Biomedical Inc. - Product / Service; Exhibit 172: Synapse Biomedical Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 173: Inclusions checklist; Exhibit 174: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 175: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 176: Research methodology; Exhibit 177: Validation techniques employed for market sizing; Exhibit 178: Information sources; 13.5 List of abbreviations; Exhibit 179: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global neurostimulation devices market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on Application - Market share 2022-2027 (%); Exhibits31: Data Table on Application - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on Pain management - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Pain management - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Pain management - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Pain management - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Urinary and fecal incontinence - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Urinary and fecal incontinence - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Urinary and fecal incontinence - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Urinary and fecal incontinence - Year-over-year growth 2022-2027 (%); Exhibits42: Chart on Parkinsons disease - Market size and forecast 2022-2027 ($ million); Exhibits43: Data Table on Parkinsons disease - Market size and forecast 2022-2027 ($ million); Exhibits44: Chart on Parkinsons disease - Year-over-year growth 2022-2027 (%); Exhibits45: Data Table on Parkinsons disease - Year-over-year growth 2022-2027 (%); Exhibits46: Chart on Epilepsy - Market size and forecast 2022-2027 ($ million); Exhibits47: Data Table on Epilepsy - Market size and forecast 2022-2027 ($ million); Exhibits48: Chart on Epilepsy - Year-over-year growth 2022-2027 (%); Exhibits49: Data Table on Epilepsy - Year-over-year growth 2022-2027 (%); Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Market opportunity by Application ($ million); Exhibits55: Data Table on Market opportunity by Application ($ million); Exhibits56: Chart on Product - Market share 2022-2027 (%); Exhibits57: Data Table on Product - Market share 2022-2027 (%); Exhibits58: Chart on Comparison by Product; Exhibits59: Data Table on Comparison by Product; Exhibits60: Chart on Implantable neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibits61: Data Table on Implantable neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibits62: Chart on Implantable neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibits63: Data Table on Implantable neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibits64: Chart on External neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibits65: Data Table on External neurostimulation devices - Market size and forecast 2022-2027 ($ million); Exhibits66: Chart on External neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibits67: Data Table on External neurostimulation devices - Year-over-year growth 2022-2027 (%); Exhibits68: Market opportunity by Product ($ million); Exhibits69: Data Table on Market opportunity by Product ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million); Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million); Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%); Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2022 and 2027; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Abbott Laboratories - Overview; Exhibits120: Abbott Laboratories - Business segments; Exhibits121: Abbott Laboratories - Key news; Exhibits122: Abbott Laboratories - Key offerings; Exhibits123: Abbott Laboratories - Segment focus; Exhibits124: ALEVA NEUROTHERAPEUTICS SA - Overview; Exhibits125: ALEVA NEUROTHERAPEUTICS SA - Product / Service; Exhibits126: ALEVA NEUROTHERAPEUTICS SA - Key offerings; Exhibits127: Bayer AG - Overview; Exhibits128: Bayer AG - Business segments; Exhibits129: Bayer AG - Key news; Exhibits130: Bayer AG - Key offerings; Exhibits131: Bayer AG - Segment focus; Exhibits132: Boston Scientific Corp. - Overview; Exhibits133: Boston Scientific Corp. - Business segments; Exhibits134: Boston Scientific Corp. - Key news; Exhibits135: Boston Scientific Corp. - Key offerings; Exhibits136: Boston Scientific Corp. - Segment focus; Exhibits137: electroCore Inc. - Overview; Exhibits138: electroCore Inc. - Product / Service; Exhibits139: electroCore Inc. - Key offerings; Exhibits140: EndoStim Inc - Overview; Exhibits141: EndoStim Inc - Product / Service; Exhibits142: EndoStim Inc - Key offerings; Exhibits143: LABORIE MEDICAL TECHNOLOGIES CORP. - Overview; Exhibits144: LABORIE MEDICAL TECHNOLOGIES CORP. - Product / Service; Exhibits145: LABORIE MEDICAL TECHNOLOGIES CORP. - Key offerings; Exhibits146: LivaNova Plc - Overview; Exhibits147: LivaNova Plc - Business segments; Exhibits148: LivaNova Plc - Key offerings; Exhibits149: LivaNova Plc - Segment focus; Exhibits150: Medtronic Plc - Overview; Exhibits151: Medtronic Plc - Business segments; Exhibits152: Medtronic Plc - Key news; Exhibits153: Medtronic Plc - Key offerings; Exhibits154: Medtronic Plc - Segment focus; Exhibits155: NeuroMetrix Inc. - Overview; Exhibits156: NeuroMetrix Inc. - Product / Service; Exhibits157: NeuroMetrix Inc. - Key offerings; Exhibits158: NEURONETICS Inc. - Overview; Exhibits159: NEURONETICS Inc. - Product / Service; Exhibits160: NEURONETICS Inc. - Key offerings; Exhibits161: NeuroPace Inc. - Overview; Exhibits162: NeuroPace Inc. - Product / Service; Exhibits163: NeuroPace Inc. - Key offerings; Exhibits164: Nevro Corp. - Overview; Exhibits165: Nevro Corp. - Product / Service; Exhibits166: Nevro Corp. - Key offerings; Exhibits167: Soterix Medical Inc. - Overview; Exhibits168: Soterix Medical Inc. - Product / Service; Exhibits169: Soterix Medical Inc. - Key offerings; Exhibits170: Synapse Biomedical Inc. - Overview; Exhibits171: Synapse Biomedical Inc. - Product / Service; Exhibits172: Synapse Biomedical Inc. - Key offerings; Exhibits173: Inclusions checklist; Exhibits174: Exclusions checklist; Exhibits175: Currency conversion rates for US$; Exhibits176: Research methodology; Exhibits177: Validation techniques employed for market sizing; Exhibits178: Information sources; Exhibits179: List of abbreviations